PP Power Search:
Patients Like Me

Amevive (Alefacept)

Welcome to the Amevive (Alefacept) social portal on PsoriasisPatients.com.

This page will connect you with all activities and content on our site that is, in one way or another, related to the Amevive treatment. You can get access to blog entries, participate in discussion forums, view our members' treatment journals, answer opinion polls, help to answer questions or ask your own, enrol in a dedicated support group, as well as connect with people who have experience with the Amevive treatment. The resources section is also available where you can get more information about the drug as well as recommend other helpful Amevive resources. You may want to start with the basic info about this treatment below:

Drug name: Amevive® (Alefacept)

How does Amevive work?

Amevive is a protein which blocks the growth of T-cells, and acts as an immunosuppressant. The exact mechanism of action is complicated, however, the T-cell activity is weakened, which reduces the symptoms of psoriasis and the inflammation that is involved in it.

Who is a good candidate for Amevive?

Amevive is used to treat adult patients with moderate to severe plaque psoriasis.

What are possible side-effects?

Flu-like symptoms such as coughing, nausea, and chills were commonly reported, as well as itchiness and dryness of the skin.

Are there any other concerns?

Amevive suppresses the immune system, and therefore increases risk of an internal malignancy. HIV patients should not be using Amevive. Finally, Amevive may slowly lose effectiveness over time as the body begins to build tolerance for the medication.



Need More information?  

Please note that this is a very brief and basic introduction to the Amevive treatment. For detailed information about Amevive, or studies related to Amevive please look at the Amevive Resources page.

GET INVOLVED: HELP OTHERS When you share your experience with Amevive treatment other people can benefit from it.
Please consider taking part in the activities below: